Patent Application
20180073058
The present invention relates to a quick diagnosis of Anaplasma platys, and more particularly to primer pair, kit and method for detecting Anaplasma platys.
Anaplasma platys (former Ehrlichia platys) causes canine cyclic thrombocytopenia in tropical and warm regions of the world, like the Mediterranean, Asia, Middle East, Africa, Australia, and the USA. Canine anaplasmosis is a widespread disease and therefore called a “canine emerging disease”. The Brown Dog tick (Rhipicephalus sanguineus) and Dermacentor spp. are thought to transmit the pathogen. Anaplasma platys are the only rickettsia known to infect platelets. The organisms appear as round, oval or bean shaped blue cell inclusions in platelets and range from 0.35 to 1.25 μm in diameter.
Signs of Anaplasma platys infection include fever, anorexia, lethargy, primary hemostatic disorders as the pathogen destroys platelet cells of the host, mild anemia, and lymphadenomegaly. Bacteraemia and subsequent thrombocytopenic episodes (with platelet counts below 20,000/μl) recur at 1 to 2 week intervals. Co-infection with E. canis may lead to severe diseases.
Generally, the methods employed for Anaplasma platys diagnosis includes blood smear, serologic diagnosis and molecular diagnosis, but each method has some limitations.
A diagnosis of Anaplasma platys may be made by detecting organisms within platelets on stained blood films or buffy coat smears (e.g. Giemsa or Diff-Quik). Due to cyclic parasitemia the pathogen could either be absent or present in very low numbers. Thus this method is not reliable, and shows low sensitivity and time consuming.
Serologic diagnosis may be helpful in identifying the presence of antibodies to Anaplasma platys, but may not detect early infections during the acute phase of disease. The limitation of serologic diagnosis is cross-reaction, and the cross-reaction among the Ehrlichia spp. and Anaplasma spp. is commonly recognized. Moreover, it is difficult to differentiate between post exposure and present infection.
The most current and best way to diagnose Anaplasma platys is molecular diagnosis, especially by polymerase chain reaction (PCR) testing. PCR, which is more sensitive and specific technique, offers an alternative approach for the diagnosis of anaplasmosis. An 16S rRNA gene sequence has been helpful in identifying species of Anaplasma. For example, the VetPCR A. platys Detection Kit provided by BioinGentech is used to diagnose Anaplasma platys infection, and it is a very fast, accurate and reliable technique. However, end-point PCR detection method, i.e. gel electrophoresis, should be combined with this diagnostic kit, and the whole procedure will take 3 hours, which is quite labor and time consuming.
Therefore, there is a need of providing an Anaplasma platys diagnosis in order to overcome the above drawbacks.
An object of the present invention is to provide a primer pair for detecting Anaplasma platys with high sensitivity and high specificity in order to rapidly and accurately diagnose Anaplasma platys infection.
Another object of the present invention is to provide a kit for detecting Anaplasma platys with high sensitivity and high specificity in order to rapidly and accurately diagnose Anaplasma platys infection.
An additional object of the present invention is to provide a method for detecting Anaplasma platys with high sensitivity and high specificity in order to rapidly and accurately diagnose Anaplasma platys infection.
According to an aspect of the present invention, there is provided a primer pair for detecting Anaplasma platys, comprising a forward primer having a sequence of 5′-GTCGTAGCTTGCTATGATA-3′ and a reverse primer having a sequence of 5′-CCATACTACTAGGTAGATTCC-3′. The forward primer and the reverse primer are used for real-time polymerase chain reaction.
According to another aspect of the present invention, there is provided a kit for detecting Anaplasma platys, comprising a forward primer having a sequence of 5′-GTCGTAGCTTGCTATGATA-3′, a reverse primer having a sequence of 5′-CCATACTACTAGGTAGATTCC-3′ and a probe having a sequence of 5′-CTCACCCGTCTGCCACTAAC-3′. The forward primer, the reverse primer and the probe are used for real-time polymerase chain reaction. The probe is labeled with a 5′-reporter dye and a 3′-quencher.
According to an additional aspect of the present invention, there is provided a method for detecting Anaplasma platys, the method comprising amplifying nucleic acid from Anaplasma platys using real-time polymerase chain reaction with a forward primer having a sequence of 5′-GTCGTAGCTTGCTATGATA-3′, a reverse primer having a sequence of 5′-CCATACTACTAGGTAGATTCC-3′ and a probe having a sequence of 5′-CTCACCCGTCTGCCACTAAC-3′. The probe is labeled with a 5′-reporter dye and a 3′-quencher.
The above objects and advantages of the present invention become more readily apparent to those ordinarily skilled in the art after reviewing the following detailed description and accompanying drawings, in which:
The present invention will now be described more specifically with reference to the following embodiments. It is to be noted that the following descriptions of preferred embodiments of this invention are presented herein for purpose of illustration and description only; it is not intended to be exhaustive or to be limited to the precise form disclosed.
The present invention utilizes real-time polymerase chain reaction (Real-time PCR), also called quantitative polymerase chain reaction (Q-PCR), with probe-based detection for detecting Anaplasma platys. In Real-time PCR, the specific forward and reverse primers and probe hybridize to the DNA target of Anaplasma platys, wherein the probe is labeled with a 5′-reporter dye and a 3′-quencher. During PCR amplification, the probe is cleaved and the reporter dye and quencher are separated, so that the resulting increase in fluorescence can be detected. In an embodiment, the reporter dye is FAM fluorescence, and the quencher is BHQ1 group.
The DNA target for this assay is a variable region of the 16S rRNA gene (GenBank accession number: U54806.1) that contains sequence that is species-specific for Anaplasma platys. PCR primers and probe are designed using Primer3 and chosen on the basis of GC content and lack of hairpin structures.
To ascertain the specificity of the PCR primers and the probe for Anaplasma platys, the primer pair, including the forward primer and the reverse primer, and the probe are checked by Primer-BLAST from NCBI, and the blast result shows that no other similar species have 100% same fragment compare to the primer pair and the probe of the present invention. The result demonstrates that the specificity of the primer pair and the probe is quite high, and the primer pair and the probe can be only used to amplify and detect the 16S rRNA gene of Anaplasma platys.
Therefore, the present invention provides a primer pair for detecting Anaplasma platys, comprising a forward primer having a sequence of 5′-GTCGTAGCTTGCTATGATA-3′ and a reverse primer having a sequence of 5′-CCATACTACTAGGTAGATTCC-3′. The present invention also provides a kit for detecting Anaplasma platys, comprising a forward primer having a sequence of 5′-GTCGTAGCTTGCTATGATA-3′, a reverse primer having a sequence of 5′-CCATACTACTAGGTAGATTCC-3′ and a probe having a sequence of 5′-CTCACCCGTCTGCCACTAAC-3′. On the other hand, the present invention also provides a method for detecting Anaplasma platys, the method comprising amplifying nucleic acid from Anaplasma platys using real-time polymerase chain reaction with a forward primer having a sequence of 5′-GTCGTAGCTTGCTATGATA-3′, a reverse primer having a sequence of 5′-CCATACTACTAGGTAGATTCC-3′ and a probe having a sequence of 5′-CTCACCCGTCTGCCACTAAC-3′.
In some other embodiments, since the primer pair of the present invention is specific to Anaplasma platys, all the sequence located between the forward primer and the reverse primer may be used as the probe sequence, and thus, the probe sequence is not limited to the aforesaid sequence. Further, the probe can be designed to hybridize to any strand of the DNA, so both the complementary sequences at the same location can be used as the probe sequence. Therefore, the complementary sequence of the aforesaid probe sequence may also be used as the probe sequence for detecting Anaplasma platys.
The following describes an example of the method for detecting Anaplasma platys of the present invention.
First, DNA is extracted from 200 μl of EDTA-preserved whole blood using the QIAamp DNA blood Mini kit for blood protocol (Qiagen) and eluted in 100 μl of elution buffer. Then the real-time PCR assay is performed on the Bio-Rad real-time PCR machine (CFX96). The PCR reaction mixture includes 10 μl of KAPA Fast probe universal master mix, 250 nM of forward and reverse primers and 250 nM of probe, wherein the forward primer has a sequence of 5′-GTCGTAGCTTGCTATGATA-3′, the reverse primer has a sequence of 5′-CCATACTACTAGGTAGATTCC-3′ and the probe has a sequence of 5′-CTCACCCGTCTGCCACTAAC-3′. 3 μl extracted DNA template is added to each reaction in a total volume of 20 μl. Cycling conditions are as follows: 95° C. for 3 min, followed by 40 cycles of denaturation at 95° C. for 3 sec, and annealing/extension at 60° C. for 20 sec.
An Anaplasma platys-positive control is constructed by cloning the partial 16S rRNA gene fragment into a vector (RBC Cloning System). A series of seven 10-fold dilutions are prepared from this recombinant plasmid DNA (10, 102, 103, 104, 105, 106 and 107 copies/μl). The dilution series are analyzed in duplicate to determine the lower limit of Anaplasma platys DNA detection and the linearity and efficiency of amplification of this real-time PCR assay.
In conclusion, the present invention provides a method for detecting Anaplasma platys using real-time PCR with specific primer pair and probe. The method of the present invention has advantage of high sensitivity, and should allow the detection of low Anaplasma platys in subclinically infected cases. Moreover, diagnosis in early stage or acute phase is very critical for Anaplasma platys treatment; some studies show that when dogs are treated in the acute phase of anaplasmosis, they improve quickly, within 24-48 hours, and their prognosis is good when the whole courses of therapy are administered. The method of the present invention further has advantage of high specificity, which is able to specifically differentiate Anaplasma platys with other tick-borne pathogens and is very helpful for vets to choose the optimal treatment program. In addition, in recurrent disease after treatment or failure after treatment, the method of the present invention could determine if the original diagnosis was incorrect, so as to reduce risk of transfusion transmission by testing blood donors.
While the invention has been described in terms of what is presently considered to be the most practical and preferred embodiments, it is to be understood that the invention needs not be limited to the disclosed embodiment. On the contrary, it is intended to cover various modifications and similar arrangements included within the spirit and scope of the appended claims which are to be accorded with the broadest interpretation so as to encompass all such modifications and similar structures.
| Number | Date | Country | Kind |
|---|---|---|---|
| 10201706362X | Aug 2017 | SG | national |
This application claims the benefit of U.S. Provisional Application Ser. No. 62/393,204 filed on Sep. 12, 2016, and claims the priority to Singapore Patent Application No. 10201706362X filed on Aug. 3, 2017, the entire contents of which are incorporated herein by reference for all purposes.
| Number | Date | Country | |
|---|---|---|---|
| 62393204 | Sep 2016 | US |
